2019
DOI: 10.1093/ije/dyz182
|View full text |Cite
|
Sign up to set email alerts
|

Phenome-wide Mendelian-randomization study of genetically determined vitamin D on multiple health outcomes using the UK Biobank study

Abstract: BackgroundVitamin D deficiency is highly prevalent across the globe. Existing studies suggest that a low vitamin D level is associated with more than 130 outcomes. Exploring the causal role of vitamin D in health outcomes could support or question vitamin D supplementation.MethodsWe carried out a systematic literature review of previous Mendelian-randomization studies on vitamin D. We then implemented a Mendelian Randomization–Phenome Wide Association Study (MR-PheWAS) analysis on data from 339 256 individuals… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
44
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 62 publications
(50 citation statements)
references
References 34 publications
(36 reference statements)
5
44
0
1
Order By: Relevance
“…In a Danish study of 96 423 adults, genetic variants associated with low blood 25(OH)D levels predicted incident type 2 diabetes ( 33 ). However, other studies in different cohorts have reported no associations between genetic variants that specifically affect blood 25(OH)D level and incident diabetes ( 30–32 , 34 ). Mendelian randomization studies center upon certain assumptions that may not apply to vitamin D. Specifically, the tested alleles accounted for less than 5% of the variance in blood 25(OH)D level.…”
Section: Review Strategy and Literature Searchmentioning
confidence: 89%
“…In a Danish study of 96 423 adults, genetic variants associated with low blood 25(OH)D levels predicted incident type 2 diabetes ( 33 ). However, other studies in different cohorts have reported no associations between genetic variants that specifically affect blood 25(OH)D level and incident diabetes ( 30–32 , 34 ). Mendelian randomization studies center upon certain assumptions that may not apply to vitamin D. Specifically, the tested alleles accounted for less than 5% of the variance in blood 25(OH)D level.…”
Section: Review Strategy and Literature Searchmentioning
confidence: 89%
“…As shown for breast cancer, risk changes more rapidly below 20 ng/ml than above 20 ng/ml (16). A recent article on the MR study stated (46) Another MR study published around the same time supported that statement. For the Copenhagen data sets, the HR for a 10-ng/ml increase in the MR genetically determined 25(OH)D concentration and cancer mortality rate was 0.97 (95% CI=0.94-1.10; p=0.06), whereas the HR for 10 ng/ml of serum 25(OH)D concentration was 0.93 (95% CI=0.88-0.98) (47).…”
Section: Mendelian Randomization (Mr) Studiesmentioning
confidence: 97%
“…A Mendelian randomisation study analysing depressive symptoms and broadly defined depression in two large population studies (> 480,000 participants) did not find an association of the alleles linked to serum 25(OH)D with these depression phenotypes [189]. The Mendelian randomisation study with 339,256 UK biobank participants (including 23,294 cases with depression) by Meng et al (2019) did also not support a causal role of life-long serum 25(OH)D reduction on depression [190].…”
Section: Discussionmentioning
confidence: 95%
“…In contrast, Mendelian randomisation studies do not support a causal role of (genetically) lower levels of serum 25(OH)D on the development of depressive symptoms or major depressive disorders. Recently, two additional Mendelian randomisation studies concerning 25(OH)D and depression were published (after the search period) [189,190]. A Mendelian randomisation study analysing depressive symptoms and broadly defined depression in two large population studies (> 480,000 participants) did not find an association of the alleles linked to serum 25(OH)D with these depression phenotypes [189].…”
Section: Discussionmentioning
confidence: 99%